Amit Sharma
Company: Alexion Pharmaceuticals
Job title: Vice President & Head Of Clinical Development & Global Therapeutic Area Nephrology & Hematology
Seminars:
Repositioning AKI at the Forefront of R&D: Targeting Complex Pathophysiology, Overcoming Heterogeneity & Enhancing Return on Investment 11:00 am
The heterogeneity across phenotypic subtypes has made AKI significantly difficult to study, therefore making progress of new specific treatments and disease management rather stagnant in recent years. From balancing the need for AKI resolution while minimizing long-term kidney damage, to addressing AKI subtypes with medical interventions that target specific underlying causes, tackle key questions with…Read more
day: Pre-Conference Workshop Day
Minimizing Patient Burden & Expanding Recruitment Efforts to Promote Diversity in CKD Trials 8:30 am
Gaining a deeper comprehension of the factors contributing to the underrepresentation of minorities in CKD studies Exploring what can be done, from leveraging social media to collaborating with advocacy groups, to revolutionize recruitment strategies Evaluating what is being done on a site, study and global level to reduce patient burden and encourage participationRead more
day: Conference Day 2
Clinical Progress in Regenerative Medicine: Striving Towards a One-Dose Cure for CKD 10:25 am
day: Day 2 Track 2 AM